AAAAAA

   
Results: 1-14 |
Results: 14
DETERMINANTS OF GD-ENHANCED MRI RESPONSE TO IFN-BETA-I A TREATMENT INRELAPSING-REMITTING MULTIPLE-SCLEROSIS
Authors: KOUDRIAVTSEVA T POZZILLI C FIORELLI M GASPERINI C BAGNATO F GALGANI S FRONTONI M CICCARELLI O BASTIANELLO S
Citation: T. Koudriavtseva et al., DETERMINANTS OF GD-ENHANCED MRI RESPONSE TO IFN-BETA-I A TREATMENT INRELAPSING-REMITTING MULTIPLE-SCLEROSIS, Multiple sclerosis, 4(5), 1998, pp. 403-407
EFFECT OF STEROIDS ON GD-ENHANCING LESIONS BEFORE AND DURING RECOMBINANT BETA-INTERFERON 1A TREATMENT IN RELAPSING-REMITTING MULTIPLE-SCLEROSIS
Authors: GASPERINI C POZZILLI C BASTIANELLO S KOUDRIAVTSEVA T GALGANI S MILLEFIORINI E PAOLILLO A HORSFIELD MA BOZZAO L FIESCHI C
Citation: C. Gasperini et al., EFFECT OF STEROIDS ON GD-ENHANCING LESIONS BEFORE AND DURING RECOMBINANT BETA-INTERFERON 1A TREATMENT IN RELAPSING-REMITTING MULTIPLE-SCLEROSIS, Neurology, 50(2), 1998, pp. 403-406
MRI MEASURES AND THEIR RELATIONS WITH CLINICAL DISABILITY IN RELAPSING-REMITTING AND SECONDARY PROGRESSIVE MULTIPLE-SCLEROSIS
Authors: GIUGNI E POZZILLI C BASTIANELLO S GASPERINI C PAOLILLO A KOUDRIAVTSEVA T FRONTONI M FARINA D BOZZAO L
Citation: E. Giugni et al., MRI MEASURES AND THEIR RELATIONS WITH CLINICAL DISABILITY IN RELAPSING-REMITTING AND SECONDARY PROGRESSIVE MULTIPLE-SCLEROSIS, Multiple sclerosis, 3(4), 1997, pp. 221-225
FAST SPIN-ECHO AND FAST FLUID-ATTENUATED INVERSION-RECOVERY VERSUS CONVENTIONAL SPIN-ECHO SEQUENCES FOR MR QUANTIFICATION OF MULTIPLE-SCLEROSIS LESIONS
Authors: BASTIANELLO S BOZZAO A PAOLILLO A GIUGNI E GASPERINI C KOUDRIAVTSEVA T MILLEFIORINI E HORSFIELD MA COLONNESE C TONI D FIORELLI M POZZILLI C BOZZAO L
Citation: S. Bastianello et al., FAST SPIN-ECHO AND FAST FLUID-ATTENUATED INVERSION-RECOVERY VERSUS CONVENTIONAL SPIN-ECHO SEQUENCES FOR MR QUANTIFICATION OF MULTIPLE-SCLEROSIS LESIONS, American journal of neuroradiology, 18(4), 1997, pp. 699-704
GADOLINIUM-ENHANCED MRI PREDICTS CLINICAL AND MRI DISEASE-ACTIVITY INRELAPSING-REMITTING MULTIPLE-SCLEROSIS
Authors: KOUDRIAVTSEVA T THOMPSON AJ FIORELLI M GASPERINI C BASTIANELLO S BOZZAO A PAOLILLO A PISANI A GALGANI S POZZILLI C
Citation: T. Koudriavtseva et al., GADOLINIUM-ENHANCED MRI PREDICTS CLINICAL AND MRI DISEASE-ACTIVITY INRELAPSING-REMITTING MULTIPLE-SCLEROSIS, Journal of Neurology, Neurosurgery and Psychiatry, 62(3), 1997, pp. 285-287
NO INCREASE OF SERUM AUTOANTIBODIES DURING THERAPY WITH RECOMBINANT HUMAN INTERFERON-BETA(1A) IN RELAPSING-REMITTING MULTIPLE-SCLEROSIS
Authors: COLOSIMO C POZZILLI C FRONTONI M FARINA D KOUDRIAVTSEVA T GASPERINI C SALVETTI M VALESINI G
Citation: C. Colosimo et al., NO INCREASE OF SERUM AUTOANTIBODIES DURING THERAPY WITH RECOMBINANT HUMAN INTERFERON-BETA(1A) IN RELAPSING-REMITTING MULTIPLE-SCLEROSIS, Acta neurologica Scandinavica, 96(6), 1997, pp. 372-374
THE INFLUENCE OF CLINICAL RELAPSES AND STEROID-THERAPY ON THE DEVELOPMENT OF GD-ENHANCING LESIONS - A LONGITUDINAL MRI STUDY IN RELAPSING-REMITTING MULTIPLE-SCLEROSIS PATIENTS
Authors: GASPERINI C POZZILLI C BASTIANELLO S KOUDRIAVTSEVA T COLLELUORI A MILLEFIORINI E THOMPSON AJ HORSFIELD MA GALGANI S BOZZAO L FIESCHI C
Citation: C. Gasperini et al., THE INFLUENCE OF CLINICAL RELAPSES AND STEROID-THERAPY ON THE DEVELOPMENT OF GD-ENHANCING LESIONS - A LONGITUDINAL MRI STUDY IN RELAPSING-REMITTING MULTIPLE-SCLEROSIS PATIENTS, Acta neurologica Scandinavica, 95(4), 1997, pp. 201-207
HIGH-DOSE CONTRAST-ENHANCED MRI IN MULTIPLE-SCLEROSIS
Authors: KOUDRIAVTSEVA T POZZILLI C DIBIASI C IANNILLI M TRASIMENI G GASPERINI C ARGENTINO C GUALDI GF
Citation: T. Koudriavtseva et al., HIGH-DOSE CONTRAST-ENHANCED MRI IN MULTIPLE-SCLEROSIS, Neuroradiology, 38, 1996, pp. 5-9
EFFECT OF STEROIDS ON GADOLINIUM-ENHANCING LESIONS BEFORE AND AFTER RECOMBINANT INTERFERON-BETA TREATMENT - A STUDY IN RELAPSING, REMITTINGMULTIPLE-SCLEROSIS
Authors: GASPERINI C POZZILLI C KOUDRIAVTSEVA T BASTIANELLO S GALGANI S MILLEFIORINI E BOZZAO L FIESCHI C
Citation: C. Gasperini et al., EFFECT OF STEROIDS ON GADOLINIUM-ENHANCING LESIONS BEFORE AND AFTER RECOMBINANT INTERFERON-BETA TREATMENT - A STUDY IN RELAPSING, REMITTINGMULTIPLE-SCLEROSIS, Neurology, 46(2), 1996, pp. 3091-3091
SURROGATE MARKERS OF DISEASE-ACTIVITY IN MULTIPLE-SCLEROSIS - MONTHLYENHANCED IMAGING VERSUS 6-MONTH T2 ASSESSMENT
Authors: BASTIANELLO S POZZILLI C GASPERINI C KOUDRIAVTSEVA T BOZZAO A PAOLILLO A GIUGNI E BOZZAO L
Citation: S. Bastianello et al., SURROGATE MARKERS OF DISEASE-ACTIVITY IN MULTIPLE-SCLEROSIS - MONTHLYENHANCED IMAGING VERSUS 6-MONTH T2 ASSESSMENT, Neurology, 46(2), 1996, pp. 5094-5094
THE EFFECT OF RIFN-BETA-1A ON MONTHLY GADOLINIUM-ENHANCED MRI AND RELAPSE RATE IN MULTIPLE-SCLEROSIS - RESULTS OF 9-MONTH TREATMENT PERIOD
Authors: CARLO P KOUDRIAVTSEVA T GASPERINI C BASTIANELLO S BUTTINELLI C FARONI J PIAZZA G FIESCHI C
Citation: P. Carlo et al., THE EFFECT OF RIFN-BETA-1A ON MONTHLY GADOLINIUM-ENHANCED MRI AND RELAPSE RATE IN MULTIPLE-SCLEROSIS - RESULTS OF 9-MONTH TREATMENT PERIOD, Neurology, 46(2), 1996, pp. 52004-52004
MAGNETIC-RESONANCE-IMAGING CHANGES WITH RECOMBINANT HUMAN INTERFERON-BETA-1A - A SHORT-TERM STUDY IN RELAPSING-REMITTING MULTIPLE-SCLEROSIS
Authors: POZZILLI C BASTIANELLO S KOUDRIAVTSEVA T GASPERINI C BOZZAO A MILLEFIORINI E GALGANI S BUTTINELLI C PERCIACCANTE G PIAZZA G BOZZAO L FIESCHI C
Citation: C. Pozzilli et al., MAGNETIC-RESONANCE-IMAGING CHANGES WITH RECOMBINANT HUMAN INTERFERON-BETA-1A - A SHORT-TERM STUDY IN RELAPSING-REMITTING MULTIPLE-SCLEROSIS, Journal of Neurology, Neurosurgery and Psychiatry, 61(3), 1996, pp. 251-258
INVOLVEMENT OF THE LIMBIC SYSTEM IN MULTIPLE-SCLEROSIS PATIENTS WITH DEPRESSIVE-DISORDERS
Authors: SABATINI U POZZILLI C PANTANO P KOUDRIAVTSEVA T PADOVANI A MILLEFIORINI E DIBIASI C GUALDI GF SALVETTI M LENZI GL
Citation: U. Sabatini et al., INVOLVEMENT OF THE LIMBIC SYSTEM IN MULTIPLE-SCLEROSIS PATIENTS WITH DEPRESSIVE-DISORDERS, Biological psychiatry, 39(11), 1996, pp. 970-975
FATIGUE IN MS IS ASSOCIATED WITH SPECIFIC CLINICAL-FEATURES
Authors: COLOSIMO C MILLEFIORINI E GRASSO MG VINCI F FIORELLI M KOUDRIAVTSEVA T POZZILLI C
Citation: C. Colosimo et al., FATIGUE IN MS IS ASSOCIATED WITH SPECIFIC CLINICAL-FEATURES, Acta neurologica Scandinavica, 92(5), 1995, pp. 353-355
Risultati: 1-14 |